MyAverix Finance
HK · Healthcare
Hua Medicine (2552)
Drug Manufacturers - Specialty & Generic
Hua Medicine (2552) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $3.37B, P/E ratio is 2.68, net margin is 224.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2552
Hua Medicine (2552) — FAQ
What is Hua Medicine's market cap?
Hua Medicine (2552) has a reported market cap of $3.37B (data as of 2026-05-21).
What is 2552's P/E ratio?
The price-to-earnings (P/E) ratio for Hua Medicine (2552) is 2.68 (data as of 2026-05-21).
Does Hua Medicine pay a dividend?
Dividend yield is not available in the current snapshot for Hua Medicine (2552). Check the MyAverix Finance app for the latest dividend data.
What sector is Hua Medicine in?
Hua Medicine (2552) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2552 listed on?
2552 is listed on HK.
What is Hua Medicine's net margin?
Hua Medicine (2552) reports a net margin of 224.4% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.